Date: Fri, 29 Mar 2024 09:45:52 -0400 (EDT) Message-ID: <1904698865.1036.1711719952772@ip-10-208-27-219.ec2.internal> Subject: Exported From Confluence MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_Part_1035_1947577318.1711719952769" ------=_Part_1035_1947577318.1711719952769 Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Location: file:///C:/exported.html
The following ISA-TAB-Nano curated examples are using Version 1.2 of the ISA-TAB-Nano s= pecification.
2. Lo ST, Stern S, Clogston JD, Zheng J, Adiseshaia=
h PP, Dobrovolskaia M, Lim J, Patri AK, Sun X, Simanek EE. Biological =
assessment of triazine dendrimer: toxicological profiles, solution behavior=
, biodistribution,
drug release and efficacy in a PEGylated, pacl=
itaxel construct. Mol Pharm 7:993-1006 (2010).
2014-05-02 UTSMC_TAM_NCL-SLoMP2010v1.2.zip
3. Efthimiadou EK, Tapeinos C, Chatzipavlidis = A, Boukos N, Fragogeorgi E, Palamaris L, Loudos G, Kordas G. Dynamic in viv= o imaging of dual-triggered microspheres for sustained release applications= : synthesis, characterization and cytotoxicity study Int J Pharm. 461:54-63= (2014).
2014-06-30 NCSR_UP_TEI-EEfthimiadouIJP2014v1.2.zip
4. Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri = FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, Daniel WL, Scott AW, Rotz MW,= Meade TJ, Giljohann DA, Mirkin CA, Stegh AH. Spherical nucleic acid nanopa= rticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med= 5:209ra152 (2013).
2016-10-14= NWU-SJensenSTM2013v1.2.zip
5. Wen CY, Wu LL, Zhang ZL, Liu YL, Wei SZ, Hu J, Tan= g M, Sun EZ, Gong YP, Yu J, Pang DW. Quick-response magnetic nanospheres fo= r rapid, efficient capture and sensitive detection of circulating tumor cel= ls. ACS Nano. 8:941-9 (2014).
201= 5-03-04 WU_HCH-CWenACSNano2014v1.2.zip
6. Han H, Davis ME. Targeted nanoparticles assemb= led via complexation of boronic-acid-containing targeting moieties to= diol-containing polymers. Bioconjug Chem. 24:669-77 (2013). Han, Davi= s ME. Single-antibody, targeted nanoparticle delivery of camptothecin. Mol = Pharm. 10:2558-67 (2013).
2015-02-04 Caltec= h-HHanBC2013v1.2.zip
7. Gaur S, Wang Y, Kretzner L, Chen L, Yen T, Wu X, Yuan YC= , Davis M, Yen Y. Pharmacodynamic and pharmacogenomic study of the nanopart= icle conjugate of camptothecin CRLX101 for the treatment of cancer. &n= bsp; Nanomedicine 10:1477-1486 (2014).
2015-02-27 BRICH_Caltech_TMU-SGaurNNMB2014v1.2.zip
8. Guan YY, Luan X, Xu JR, Liu YR, Lu Q, Wang C, Liu HJ, Gao= YG, Chen HZ, Fang C. Selective eradication of tumor vascular pericyte= s by peptide-conjugated nanoparticles for antiangiogenic therapyof melanoma= lung metastasis. Biomaterials 35:3060-3070 (2014).
2015-08-26 SJTU-YGuanBM2014v= 1.2.zip
9. Perica K, Tu A, Richter A, Bieler JG, Edidin M, Schneck JP= . Magnetic-induced T cell receptor clustering by nanoparticles enhance= s T cell activation and stimulates antitumor activity. ACS Nano 8:2252-2260= .
2015-07-03= JHU_MB-KPericaACSNano2014v1.2.zip
10. Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, Yao C, Zhou = Q, Kwon M, Hartman JA, Dobrucki IT, Dobrucki LW, Borst LB, Lezmi S, He= lferich WG, Ferguson AL, Fan TM, Cheng J. Investigating the optimal si= ze of anticancer nanomedicine Proc Natl Acad Sci U S A = 111:15344-9 (2014).
2015-= 10-01 UI-UC_GPC_NCSU-LTangPNAS2014v1.2.zip
11. Ayala-Orozco C, Urban C, Knight MW, Urban AS, Neumann O, Bishn= oi SW, Mukherjee S, Goodman AM, Charron H, Mitchell T, Shea M, Roy R, = Nanda S, Schiff R, Halas NJ, Joshi A. Au nanomatryoshkas as efficient = near-infrared photothermal transducers for cancer treatment: benchmark= ing against nanoshells. ACS Nano. 8:6372-6381 (2014).
2015-10-01 RU_BCM-CAyala-OrozcoACSNano2014v1.2.zip
12. Sykes EA, Chen J, Zheng G, Chan WC Investigating the impact of = nanoparticle size on active and passive tumor targeting efficiency. AC= SNano 8:5698-5706 (2014).
2017-04-10 UT_OCI-ASykesACSNano2014v1.2.zip
13. Wang Q, Ren Y, Mu J, Egilmez NK, Zhuang X, Deng Z, Zhang L, Yan J, M= iller D, Zhang HG. Grapefruit-Derived Nanovectors Use an Activated Leukocyt= e Trafficking Pathway to Deliver TherapeuticAgents to Inflammatory Tumor Si= tes. Cancer Res 75:2520-2529 (2015).
2016-05-24 LVAMC_UL_HFPH-QWangCR2015v1.2.zip
14. Reuter KG, Perry JL, Kim D, L= uft JC, Liu R, DeSimone JM. Targeted PRINT Hydrogels: The Role of Nanoparti= cle Size and Ligand Density on Cell Association, Biodistribution, and Tumor= Accumulation. Nano Lett. 15:6371-6378 (2015)
2016-11-07 UNC-KReuterNL2015v1.2.zip
15. Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P. S= pecific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer = by RNA Nanotechnology. Mol Ther. 24:1267-77 (2016).
2017-01-04 OSU_UK_NDSU-= DBinzelMT2016v1.2.zip
16. Senzer N, Nemunaitis J, Nemunaitis D, Bedell C, Edelman G, Barve M, = Nunan R, Pirollo KF, Rait A, Chang EH. Phase I study of a systemically deli= vered p53 nanoparticle in advanced solid tumors. Mol Ther 21:1096-1103 (201= 3).
2017-= 02-13 MCCRC_TO_MDDH_GU_SGT-NSenzerMT2013v1.2.zip
17. Pirollo KF, Nemunaitis J, Leung PK, Nunan R, Adams J, Chang EH. Safe= ty and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying= the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study. Mol The= r 24:1697-1706 (2016).
2017-03-03 GU_MCCRC_Gradalis_TO_MCDH_SGT-KPirolloMT2016v1.2= .zip
18. Siefker-Radtke A, Zhang XQ, Guo CC, Shen Y, Pirollo KF, Sabir S, Leu= ng C, Leong-Wu C, Ling CM, Chang EH, Millikan RE, Benedict WF. A Phase l St= udy of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourin= ary Cancers. Mol Ther 24:1484-1491 (2016).
2017-03-03 UTMDACC_UT_GU_SGT-ASiefker-RadtkeMT2016v1.2.zip
19. Le DHT, Lee KL, Shukla S, Commandeur U, Steinmetz NF Potato virus X,= a filamentous plant viral nanoparticle for doxorubicin delivery in cancer = therapy. Nanoscale 9:2348-2357 (2017).
2017-07-11 CWRU_RWTH-Aachen-DLeNanoscale2017v1.2.zip
20. He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, Montgom= ery SA, Yuan H, Li Z, Alakhova D, Sokolsky M, Darr DB, Perou CM, Jord= an R, Luxenhofer R, Kabanov AV. A high capacity polymeric micelle of paclit= axel: Implication of high dose drug therapy to safety and in vivo anti-canc= er activity. Biomaterials 101:296-309 (2016).
2018-01-12 UNC_TUD_NCL_JMWU_MSSU_LMSU-ZHeBMat2016v1.2.zip
21. Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Stern ST, Barenholz = Y, Gabizon A Coencapsulation of alendronate and doxorubicin in pegylated li= posomes: a novel formulation for chemoimmunotherapy of cancer. J Drug Targe= t. 24:878-889 (2016).
2017-09-28 SZMC_HU_= NCL-HShmeedaJDT2016v1.2.zip
22. Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Song Q, Wei X, Chen H,= Gao X, Chen J Nanoparticles Coated with Neutrophil Membranes Can Effective= ly Treat Cancer Metastasis ACS Nano 11:1397-1411 (2017).
2018-01-12 FU_SJTU-TKangA= CSNano2017v1.2.zip
23. Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fan= g RH, Zhang L, Lu W. A facile approach to functionalizing cell membrane-coa= ted nanoparticles with neurotoxin-derived peptide for brain-targeted drug d= elivery. J Control Release. 264:102-111 (2017).
2018-03-23 FU_UCSD-ZChaiJ= RC2017v1.2.zip
24. Bressler EM, Kim J, Shmueli RB, Mirando AC, Bazzazi H, Lee E, Popel = AS, Pandey NB, Green JJ. Biomimetic peptide display from a polymeric nanopa= rticle surface for targeting and antitumor activity to human triple-negativ= e breast cancer cells. J Biomed Mater Res A. 2018 (in press)
2018-04-18 AsclepiXTher-JHU-EBresselJBMR2018v1.2.zip
25. Nascimento AV, Singh A, Bousbaa H, Ferreira D, Sarmento B, Amiji MM.= Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 si= lencing siRNA delivered systemically using EGFR-targeted chitosan nanoparti= cles Acta Biomat 47:71-80 (2017).
2018 = 06 26 CESPU_UP_NEU-ANascimentoAB2017v1.2.zip
26. Lu YJ, Lin PY, Huang PH, Kuo CY, Shalumon KT, Chen MY, Chen JP = Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Phot= othermal Therapy Nanomaterials 8:193 (2018).
2018 08 10 CGU_CGMH_CGUST_MCUT-YJLuNanomat2018v1.2.zip
27. Vogus DR, Evans MA, Pusuluri A, Barajas A, Zhang M, Krishnan V, Nowa= k M, Menegatti S, Helgeson ME, Squires TM, Mitragotri S. A hyaluronic= acid conjugate engineered to synergistically and sequentially delivery gem= citabine and doxorubicin to treat triple negative breast cancer. J Control = Release 267:191-202 (2017).
2019 04 04 UCSB_HU-DVog= usJCR2017v1.2.zip
28. Pathak RK, Basu U, Ahmad A, Sarkar S, Kumar A= a>, Surnar B, Ansari S, Wilczek K, Ivan ME, Marples B, Kolishetti = N, Dhar S. A designer bo= w-tie combination therapeutic platform: An approach to resistant cancer tre= atment by simultaneous delivery of cytotoxic and anti-inflammatory agents a= nd radiation. Bio= materials. 187:117-129 (2018).
201= 9 04 04 UMMSM_UG_FIU-RPathakBMat2018v1.2.zip
29. He=C3=9Fe C, Kollenda S, Rotan O, Pastille E, Adamc= zyk A, Wenzek C, Hansen W, Epple M, Buer J, Westendorf AM, Knus= chke T. Tumor-Peptide-Based Nanoparticle = Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy.<= /a> Mol Cancer Ther. 18:1069-1080 (2019).
2019 07 16 UDE_CeNIDE-CHesseMCT2019v1.2.zip
30. Parayath NN, Gandham SK, Leslie F, Am= iji MM. Improved anti-tumor efficacy of paclitaxel in combination with Micr= oRNA-125b-based tumor-associated macrophage repolarization in epithelial ov= arian cancer. Cell Lett 461:1-9 (2019).
2020 01 15 NEU-NParay= athCL2019v1.2.zip
31. Crecente-Campo J, Guerra-Varela J, Peleteiro M, Guti=C3=A9rrez-= Lovera C, Fern=C3=A1ndez-Mari=C3=B1o I, Di=C3=A9guez-Docampo A, Gonz=C3=A1l= ez-Fern=C3=A1ndez =C3=81, S=C3=A1nchez L, Alonso MJ. The size and comp= osition of polymeric nanocapsules dictate their interaction with macrophage= s and biodistribution in zebrafish. J Control Release. 308:98-108 (2019)
2021-= 07-19 USC_UV-JCrecente-CampoJCR2019.v1.2.zip
32. Mendes LP, Sarisozen C, Luther E, Pan J, Torchilin VP Surface-e= ngineered polyethyleneimine-modified liposomes as novel carrier of siRNA an= d chemotherapeutics for combination treatment of drug-resistant cancers. Dr= ug Deliv 26:443-458 (2019).
2020 01 15 NEU-LMendesDD2= 019v1.2.zip
33. Cole G, Ali AA, McErlean E, = Mulholland EJ, Short A, McCrudden CM, McCaffrey J, Robson T, Kett VL, Coult= er JA, Dunne NJ, Donnelly RF, McCarthy HO DNA vaccination v= ia RALA nanoparticles in a microneedle delivery system induces a potent imm= une response against the endogenous prostate cancer stem cell antigen. = ;Acta Biomater. 96:480-490 (2019).
2020 05 12 QUB_UBC_UCC_RCS_DCU-GColeAB2= 019v1.2.zip
34. Rastinehad AR, Anastos= H, Wajswol E, Winoker JS, Sfakianos JP, Doppalapudi SK, Carrick MR, Knauer= CJ, Taouli B, Lewis SC, Tewari AK, Schwartz JA, Canfield SE, George AK, We= st JL, Halas N Gold nanoshell-localized photothermal ablation of prost= ate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A = 116(37):18590-18596 (2019).
2020 05 12 ISMMS_NB_MGMSUTHSCH_MMUM_DU_RU-ARRastinehadPNAS2019v1.2.zip= a>
ISA-TAB-Nano Curated Examp= les (ISA-TAB-Nano Version 1.1)
The following ISA-TAB-Nano curated examples are using Version 1.1 of the ISA-TAB-Nano speci= fication.
1. Decuzzi P, Godin B, Tanaka T, Lee S.-Y, Chiappini C, Liu = X, Ferrari M. Size and shape effects in the biodistribution of intravascula= rly injected particles. J Control Release 141:320-327 (2010).
2013-07-12 UTHSCH_UMG_MDACC_RU_UTA_PDecuzziJCR2010v1.1.zip<= /a>
2. Park J, Wrzesinski SH, Stern E, Look M, Criscione J, Ragheb R, Jay SM=
, Demento SL, Agawu A, Licona Limon P, Ferrandino AF, Gonzalez D, Habermann=
A, Flavell RA, Fahmy TM.
Combination delivery of TGF-beta inhibitor and IL-2 by nanoscale liposomal=
polymeric gels enhances tumour immunotherapy. Nat Mater. 11:895-905 (2012)=
.
2013-11-18 YALE_H= HMI-JParkNatureMat2012v1.1.zip
3. Khatun Z, Nurunnabi M, Reeck GR, Cho KJ, Lee YK. Oral delivery of tau= rocholic acid linked heparin-docetaxel conjugates for cancer therapy. J Con= trol Release 170:74-82 (2013).
2014-09-24 KNUT_KSU= _CUK-ZKhatunJCR2013.zip
4. Zaric M, Lyubomska O, Touzelet O, Poux C, Al-Zahrani S, Fay F, W= allace L, Terhorst D, Malissen B, Henri S, Power UF, Scott CJ, Donnelly RF,= Kissenpfennig A. Skin dendritic cell targeting via microneedle arrays lade= n with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles ind= uces efficient antitumor and antiviral immune responses. ACS Nano 7:2042-20= 55 (2013).
2013-11-11 QUB_CIML_INSERM_CNRS-MZaricACSNano2013v1.1.zip
5. Lee GY, Qian WP, Wang L, Wang YA, Staley CA, Satpathy M, Nie S, Mao H= , Yang L. Theranostic nanoparticles with controlled release of gemcitabine = for targeted therapy and MRI of pancreatic cancer. ACS Nano 7:2078-2089&nbs= p; (2013).
2014-02-04 EMORY_ONT-Gl= eeACSNano2013v1.1.zip
6. Ahn RW, Chen F, Chen H, Stern ST, Clogston JD, Patri AK, Raja MR, Swi= ndell EP, Parimi V, Cryns VL, O'Halloran TV. A novel nanoparticulate formul= ation of arsenic trioxide with enhanced therapeutic efficacy in a murine mo= del of breast cancer. Clin Cancer Res 16:3607-17 (2010).
2014-02-21 NWU_NCL-RAhnCCR2010v1.1= .zip
ISA-TAB-Nano Curated Examples (ISA-TAB-Nano Version 1.0)
The following ISA-TAB-Nano curated examples are using Version 1.0 of the ISA-TAB-Nano = specification.
1. Zhang G, Liao Y, Baker I
Surface engineering of core/shell iron/iron oxide nanopartic=
les from microemulsions for hyperthermia.
Mater Sci Eng C 30:92-97 (2010).
2013-03-21 DC_GZhangMSEC2= 010.zip
2. Decuzzi P, Godin B, Tanaka T, Lee S.-Y, Chiappini C, Liu =
X, Ferrari M.
Size and shape effects in the biodistribution of intravascul=
arly injected particles.
J Control Release 141:320-327 (2010).
2013-05-07 UTHSCH_UMG_MDACC_RU_UTA_PDecuzziJCR2010.zip
3. Kersey FR, Merkel TJ, Perry JL, Napier ME, DeSimone JM.
Effect of Aspect Ratio and Deformability on Nanopart=
icle Extravasation through Nanopores.
Langmuir 28:8733-8781 (2012).
2013-= 03-21 UNC_FKerseyLNGMR2012.zip
4. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell = T, De Witt D, Figa M, Figueiredo M, Horhota A, Low S, McDonnell K, Peeke E,= Retnarajan B, Sabnis A, Schnipper E, Song JJ, Song YH, Summa J, Tompsett D= , Troiano G, Van Geen Hoven T, Wright J, LoRusso P, Kantoff PW, Bander NH, = Sweeney C, Farokhzad OC, Langer R, Zale S. Preclinical development and clin= ical translation of a PSMA-targeted docetaxel nanoparticle with a different= iated pharmacological profile. Sci Transl Med 4:128ra39 (2012).
2013-03-21 BB_SH_KCI_DFCI_WCMC_BWH= _MIT-JHrkachSTM2012.zip
5. Galloway JF, Winter A, Lee KH, Park JH, Dvoracek CM, Devreotes P= , Searson PC. Quantitative characterization of the lipid encapsulatio= n of quantum dots for biomedical applications. Nanomedicine 8:1190-119= 9 (2012).
2013-04-10 JHU_KSU-JGallowayNNBM2012.zip
6. Zavaleta CL, Smith BR, Walton I, Doering W, Davis G, Shojaei B, = Natan MJ, Gambhir SS. Multiplexed imaging of surface enhanced Raman sc= attering nanotags in living mice using noninvasive Raman spectroscopy.= Proc Natl Acad Sci U S A 106:13511-13516 (2009).
2013-08-06 STANFORD_OM-CZavaletaPNAS2009.zip
7. Ashley CE, Carnes EC, Epler KE, Padilla DP, Phillips GK, Castill= o RE, Wilkinson DC, Wilkinson BS, Burgard CA, Kalinich RM, Townson JL,= Chackerian B, Willman CL, Peabody DS, Wharton W, Brinker CJ. Delivery= of small interfering RNA by peptide-targeted mesoporous silica nanoparticl= e-supported lipid bilayers. ACS Nano 6:2174-2188 (2012).
2013-03-21 SNL_UNM-CAshleyACSNano2012.zip
8. Jokerst JV, Cole AJ, Van de Sompel D, Gambhir SS. Gold nanorods for ovarian cancer detection with photoacoustic im= aging and resection guidance via Raman imaging in living= mice. ACS Nano 6:10366-10377 (2012).
2013-01-13 STANFO= RD-JJokerstACSNano2012.zip
9. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra= E, Pitter K, Huang R, Campos C, Habte F, Sinclair R, Brennan CW, Mellingho= ff IK, Holland EC, Gambhir SS. A brain tumor molecular imaging strategy usi= ng a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18:8= 29-834 (2012).
2013-03-21 STANFORD_MSKCC_WCMC-MKircherNatMed2012.zip
10. Thakor AS, Luong R, Paulmurugan R, Lin FI, Kempen P, Zavaleta =
C, Chu P, Massoud TF, Sinclair R, Gambhir SS. The fate and toxicity of Rama=
n-active silica-gold nanoparticles in mice.
Sci Transl Med 3:79ra33 (2011).
2013-04-15 ST= ANFORD_UC-UK-AThakorSTM2011.zip
11. Zavaleta CL, Hartman KB, Miao Z, James ML, Kempen P, Thakor AS, Niel= sen CH, Sinclair R, Cheng Z, Gambhir SS. Preclinical evaluation of Raman na= noparticle biodistribution for their potential use in clinical endoscopy im= aging. Small 7:2232-2240 (2011).